Skip to main content
Clinical Trials/CTRI/2025/09/095353
CTRI/2025/09/095353Not yet recruitingUnknown

An In-vivo Study to determine the Sun Protection Factor of Honasa Mamaearth Aqua Glow Hydrating Sunscreen Gel (Batch No: ME/AGS/19-0925/AB

Honasa Consumer Ltd.1 site in 1 country10 target enrollmentStarted: October 9, 2025

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
Change in Individual MED (iMED) score

Study Overview

Brief Summary

This is the Invivo SPF test done as per UV-B protection ISO 24444 to determine the Sun Protection Factor

Test Product:

1. Mamaearth Aqua Glow Hydrating Sunscreen Gel

Done on 10 human volunteers. Duration: 3 Days

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 65.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Individual should have ITA angle in the range of 18 t0 40, 41 to 55, and greater than 56
  • Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator.
  • Individuals who have completed a preliminary medical history evaluation.
  • Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing.
  • Individuals with no known abnormal response to sunlight.

Exclusion Criteria

  • 1.Individuals taking medication which in the opinion of the investigator would mask or interfere with the results.
  • 2.Individuals with chronic skin allergies.
  • 3.Individuals with suntan or sunburn.
  • 4.Individuals with abnormal reaction to the sun.
  • 5.Pregnant or lactating females.
  • 6.Subjects accustomed to using sun beds.
  • 7.Subjects who have participated in an SPF study within the last two months.

Outcomes

Primary Outcomes

Change in Individual MED (iMED) score

Time Frame: Day1, Day2, Day3

Secondary Outcomes

  • Not Applicable(Not Applicable)

Investigators

Sponsor
Honasa Consumer Ltd.
Sponsor Class
Pharmaceutical industry-Indian
Responsible Party
Principal Investigator
Principal Investigator

Dr Robin Chugh

CCFT Laboratories

Study Sites (1)

Loading locations...

Similar Trials